New Robust and Reproducible Stereological IHC Ki67 Breast Cancer Proliferative Assessment to Replace Traditional Biased Labeling Index

There is a pressing need for an objective decision tool to guide therapy for breast cancer patients that are estrogen receptor positive and HER2/neu negative. This subset of patients contains a mixture of luminal A and B tumors with good and bad outcomes, respectively. The 2 main current tools are o...

Descripción completa

Detalles Bibliográficos
Autores principales: Bigras, Gilbert, Dong, Wei-Feng, Canil, Sarah, Hugh, Judith, Berendt, Richard, Wood, George, Yang, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2017
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5690316/
https://www.ncbi.nlm.nih.gov/pubmed/27093453
http://dx.doi.org/10.1097/PAI.0000000000000371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5690316/
https://www.ncbi.nlm.nih.gov/pubmed/27093453
http://dx.doi.org/10.1097/PAI.0000000000000371

Ejemplares similares